The ChAdOx1 nCoV-19 adenoviral vector vaccine to prevent contracting Covid-19 caused by infection with SARS-CoV-2 has been associated with vaccine-induced immune thrombotic thrombocytopenia (VITT) primarily leading to venous thromboses. Here, we report two cases of major arterial occlusions after ChAdOx1 nCov-19 vaccination, comprising a 42-year-old woman with thrombotic occlusion of the left carotid artery, and a 62-year-old man with occlusion of distal aorta and iliac arteries. Both were successfully treated with intravenous immunoglobulins and non-heparin anticoagulant agents leading to a beneficial short-term outcome of 6 weeks in case 1 and four months in case 2.
All Keywords
【초록키워드】 Intravenous immunoglobulin, vaccination, outcome, immune, ChAdOx1, ChAdOx1 nCoV-19, adenoviral vector vaccine, thrombotic, arteries, Arterial occlusion, Prevent, venous, caused, treated, anticoagulant agent, carotid, distal, infection with SARS-CoV-2, 【제목키워드】 Treatment, vaccination, ChAdOx1, Artery,
【초록키워드】 Intravenous immunoglobulin, vaccination, outcome, immune, ChAdOx1, ChAdOx1 nCoV-19, adenoviral vector vaccine, thrombotic, arteries, Arterial occlusion, Prevent, venous, caused, treated, anticoagulant agent, carotid, distal, infection with SARS-CoV-2, 【제목키워드】 Treatment, vaccination, ChAdOx1, Artery,